|
1
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tanaka S and Arii S: Molecularly targeted
therapy for hepatocellular carcinoma. Cancer Sci. 100:1–8. 2009.
View Article : Google Scholar
|
|
3
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: Models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar
|
|
4
|
Jordan CT, Guzman ML and Noble M: Cancer
stem cells. N Engl J Med. 355:1253–1261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Suetsugu A, Nagaki M, Aoki H, Motohashi T,
Kunisada T and Moriwaki H: Characterization of CD133+
hepatocellular carcinoma cells as cancer stem/progenitor cells.
Biochem Biophys Res Commun. 351:820–824. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yin S, Li J, Hu C, Chen X, Yao M, Yan M,
Jiang G, Ge C, Xie H, Wan D, et al: CD133 positive hepatocellular
carcinoma cells possess high capacity for tumorigenicity. Int J
Cancer. 120:1444–1450. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO,
Zheng BJ and Guan XY: Identification and characterization of
tumorigenic liver cancer stem/progenitor cells. Gastroenterology.
132:2542–2556. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tang KH, Ma S, Lee TK, Chan YP, Kwan PS,
Tong CM, Ng IO, Man K, To KF, Lai PB, et al: CD133+
liver tumor-initiating cells promote tumor angiogenesis, growth,
and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
Hepatology. 55:807–820. 2012. View Article : Google Scholar
|
|
9
|
Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, Shi
GM, Zhang BH, Wu WZ, Shi YH, Wu B, et al: High expression levels of
putative hepatic stem/progenitor cell biomarkers related to tumour
angiogenesis and poor prognosis of hepatocellular carcinoma. Gut.
59:953–962. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song W, Li H, Tao K, Li R, Song Z, Zhao Q,
Zhang F and Dou K: Expression and clinical significance of the stem
cell marker CD133 in hepatocellular carcinoma. Int J Clin Pract.
62:1212–1218. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song R, Song H, Liang Y, Yin D, Zhang H,
Zheng T, Wang J, Lu Z, Song X, Pei T, et al: Reciprocal activation
between ATPase inhibitory factor 1 and NF-κB drives hepatocellular
carcinoma angiogenesis and metastasis. Hepatology. 60:1659–1673.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang R, Li Y, Xu Y, Zhou Y, Pang Y, Shen
L, Zhao Y, Zhang J, Zhou J, Wang X, et al: EMT and CSC-like
properties mediated by the IKKβ/IκBα/RelA signal pathway via the
transcriptional regulator, Snail, are involved in the
arsenite-induced neoplastic transformation of human keratinocytes.
Arch Toxicol. 87:991–1000. 2013. View Article : Google Scholar
|
|
16
|
Li HL, Zheng XZ, Wang HP, Li F, Wu Y and
Du LF: Ultrasound-targeted microbubble destruction enhances
AAV-mediated gene transfection in human RPE cells in vitro and rat
retina in vivo. Gene Ther. 16:1146–1153. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang JF, Wu CJ, Zhang CM, Qiu QY and Zheng
M: Ultrasound-mediated microbubble destruction facilitates gene
transfection in rat C6 glioma cells. Mol Biol Rep. 36:1263–1267.
2009. View Article : Google Scholar
|
|
18
|
He Y, Bi Y, Hua Y, Liu D, Wen S, Wang Q,
Li M, Zhu J, Lin T, He D, et al: Ultrasound microbubble-mediated
delivery of the siRNAs targeting MDR1 reduces drug resistance of
yolk sac carcinoma L2 cells. J Exp Clin Cancer Res. 30:1042011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hao Y, Guo L, Abudula A, Saidoula W and
Guo X: Proliferation inhibition and apoptosis enhancement of human
cervical cancer cells by ultrasound-targeted microbubble
destruction delivered double suicide genes. Int J Clin Exp Med.
7:5330–5335. 2014.
|
|
20
|
Lan X, Wu YZ, Wang Y, Wu FR, Zang CB, Tang
C, Cao S and Li SL: CD133 silencing inhibits stemness properties
and enhances chemoradiosensitivity in CD133-positive liver cancer
stem cells. Int J Mol Med. 31:315–324. 2013.
|
|
21
|
Na DC, Lee JE, Yoo JE, Oh B-K, Choi GH and
Park YN: Invasion and EMT-associated genes are up-regulated in B
viral hepatocellular carcinoma with high expression of CD133-human
and cell culture study. Exp Mol Pathol. 90:66–73. 2011. View Article : Google Scholar
|
|
22
|
Ding Q, Miyazaki Y, Tsukasa K, Matsubara
S, Yoshimitsu M and Takao S: CD133 facilitates
epithelial-mesenchymal transition through interaction with the ERK
pathway in pancreatic cancer metastasis. Mol Cancer. 13:152014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zarkoob H, Taube JH, Singh SK, Mani SA and
Kohandel M: Investigating the link between molecular subtypes of
glioblastoma, epithelial-mesenchymal transition, and CD133 cell
surface protein. PLoS One. 8:e641692013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen YS, Wu MJ, Huang CY, Lin SC, Chuang
TH, Yu CC and Lo JF: CD133/Src axis mediates tumor initiating
property and epithelial-mesenchymal transition of head and neck
cancer. PLoS One. 6:e280532011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang Y, Li Y, Wang K, Wang Y, Yin W and Li
L: P38/NF-κB/snail pathway is involved in caffeic acid-induced
inhibition of cancer stem cells-like properties and migratory
capacity in malignant human keratinocyte. PLoS One. 8:e589152013.
View Article : Google Scholar
|
|
26
|
Kumar M, Allison DF, Baranova NN, Wamsley
JJ, Katz AJ, Bekiranov S, Jones DR and Mayo MW: NF-κB regulates
mesenchymal transition for the induction of non-small cell lung
cancer initiating cells. PLoS One. 8:e685972013. View Article : Google Scholar
|
|
27
|
Wamsley JJ, Kumar M, Allison DF, Clift SH,
Holzknecht CM, Szymura SJ, Hoang SA, Xu X, Moskaluk CA, Jones DR,
et al: Activin upregulation by NF-κB is required to maintain
mesenchymal features of cancer stem-like cells in non-small cell
lung cancer. Cancer Res. 75:426–435. 2015. View Article : Google Scholar
|
|
28
|
Nomura A, Banerjee S, Chugh R, Dudeja V,
Yamamoto M, Vickers SM and Saluja AK: CD133 initiates tumors,
induces epithelial-mesenchymal transition and increases metastasis
in pancreatic cancer. Oncotarget. 6:8313–8322. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang G, Zhuo Z, Zhang Q, Xu Y, Wu S, Li L,
Xia H and Gao Y: Transfection of CXCR-4 using microbubble-mediated
ultrasound irradiation and liposomes improves the migratory ability
of bone marrow stromal cells. Curr Gene Ther. 15:21–31. 2015.
View Article : Google Scholar
|
|
30
|
Yu BF, Wu J, Zhang Y, Sung HW, Xie J and
Li RK: Ultrasound-targeted HSVtk and Timp3 gene delivery for
synergistically enhanced antitumor effects in hepatoma. Cancer Gene
Ther. 20:290–297. 2013. View Article : Google Scholar : PubMed/NCBI
|
